Pharma News

Pfizer Inc. announced that the Phase 3 SPIRE-AI (AutoInjector) trial of the investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor (PCSK9i) bococizumab administered with a pre-filled pen met its co-primary endpoints: percent change from baseline in low-density lipoprotein cholesterol (LDL-C) reduction at 12 weeks compared to placebo and proportion of patients successfully operating the pre-filled pen. The SPIRE-AI trial is the second study completed of the six SPIRE Phase 3 lipid-lowering studies, and we expect it will be part of the potential regulatory filing for bococizumab.

A new study by an international team of scientists has revealed conditions under which a body produces more superoxidea dangerous form of oxygen with the capability to destruct DNA.

With Diabetes being the theme for World Health Day this year, health experts have said that only 10 percent of Indians were aware that diabetes in its later stages damages blood vessels of the eyes, heart, nerves, feet and kidneys.

The Supreme Court was told on Tuesday that one report of a test on Maggi noodles by the government research institute has shown that the lead content was within permissible limits but monosodium glutamate (MSG) was on the higher side.

An injectable drug widely used for the treatment of type 2 diabetes along with controlled diet and proper exercise plan is likely to lead to major health improvements, suggests a new research.

Tired of conventional medicinal treatments? Try ozone therapy, used widely during World War I to disinfect wounds and which has proved to be useful in treating chronic cases of asthma, chronic obstructive airway disease, diabetic foot ulcers, various cancers and more.

Anti-oxidants are likely to be an effective method of treatment for elderly patients suffering from melanoma, finds a new study.It also identified that the older tumour cells in the worst form of skin cancer behave differently than the younger tumour cells.

A team of US researchers has found that hormone therapy, when taken within six years of menopause, may slow the progression of subclinical atherosclerosis the primary underlying pathway that leads to heart disease and stroke.

[adsense:336x280:8701650588]

Testosterone therapy can help the elderly suffering from low testosterone levels and pre-existing heart condition reduce their risks of stroke, heart attacks and death, researchers report.